The KRAS-Variant Genetic Test As a Marker of Increased Risk of Ovarian Cancer

od Keane, Florence K, Ratner, Elena S
Izdano 2010

Charged particle therapy for hepatocellular carcinoma: a commentary on a recently published meta-analysis

od Keane, Florence K., Hong, Theodore S.
Izdano u Ann Transl Med (2015)

Role and Future Directions of External Beam Radiotherapy for Primary Liver Cancer

od Keane, Florence K., Hong, Theodore S.
Izdano u Cancer Control (2017)

Current standards for clinical management of small cell lung cancer

od Farago, Anna F., Keane, Florence K.
Izdano u Transl Lung Cancer Res (2018)

Liver-Directed Radiotherapy for Hepatocellular Carcinoma

od Keane, Florence K., Wo, Jennifer Y., Zhu, Andrew X., Hong, Theodore S.
Izdano u Liver Cancer (2016)

Radiotherapy for liver tumors

od Keane, Florence K, Tanguturi, Shyam K, Zhu, Andrew X, Dawson, Laura A, Hong, Theodore S
Izdano u Hepat Oncol (2015)

Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy

od Hwang, William L., Niemierko, Andrzej, Hwang, Katie L., Hubbeling, Harper, Schapira, Emily, Gainor, Justin F., Keane, Florence K.
Izdano u JAMA Oncol (2017)

Differential inflammatory response dynamics in normal lung following stereotactic body radiation therapy with protons versus photons

od Li, Yanjing, Dykstra, Michael, Best, Till D., Pursley, Jennifer, Chopra, Nitish, Keane, Florence K., Khandekar, Melin J., Sharp, Gregory C., Paganetti, Harald, Willers, Henning, Fintelmann, Florian J., Grassberger, Clemens
Izdano u Radiother Oncol (2019)

Assessment of a Contralateral Esophagus–Sparing Technique in Locally Advanced Lung Cancer Treated With High-Dose Chemoradiation: A Phase 1 Nonrandomized Clinical Trial

od Kamran, Sophia C., Yeap, Beow Y., Ulysse, Christine A., Cronin, Catherine, Bowes, Cynthia L., Durgin, Brittany, Gainor, Justin F., Khandekar, Melin J., Tansky, Joanna Y., Keane, Florence K., Olsen, Christine C., Willers, Henning
Izdano u JAMA Oncol (2021)

A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis

od Paranjape, Trupti, Heneghan, Helen, Lindner, Robert, Keane, Florence K, Hoffman, Aaron, Hollestelle, Antoinette, Dorairaj, Jemima, Geyda, Kimberly, Pelletier, Cory, Nallur, Sunitha, Martens, John W M, Hooning, Maartje J, Kerin, Michael, Zelterman, Daniel, Zhu, Yong, Tuck, David, Harris, Lyndsay, Miller, Nicola, Slack, Frank, Weidhaas, Joanne
Izdano 2011

A KRAS-variant is a Biomarker of Poor Outcome, Platinum Chemotherapy Resistance and a Potential Target for Therapy in Ovarian Cancer

od Ratner, Elena S., Keane, Florence K., Lindner, Robert, Tassi, Renata A., Paranjape, Trupti, Glasgow, Michelle, Nallur, Sunitha, Deng, Yanhong, Lu, Lingeng, Steele, Linda, Sand, Sharon, Muller, Roman-Ulrich, Bignotti, Eliana, Bellone, Stefania, Boeke, Marta, Yao, Xiaopan, Pecorelli, Sergio, Ravaggi, Antonella, Katsaros, Dionyssios, Zelterman, Daniel, Cristea, Mihaela C., Yu, Herbert, Rutherford, Thomas J., Weitzel, Jeffrey N., Neuhausen, Susan L., Schwartz, Peter E., Slack, Frank J., Santin, Alessandro D., Weidhaas, Joanne B.
Izdano 2011